tiprankstipranks
Enzo Biochem (ENZ)
NYSE:ENZ

Enzo Biochem (ENZ) Stock Price & Analysis

169 Followers

ENZ Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.16 - $2.74
Previous Close$1.27
Volume45.47K
Average Volume (3M)97.36K
Market Cap
$65.06M
Enterprise Value$2.80M
Total Cash (Recent Filing)$69.21M
Total Debt (Recent Filing)$6.95M
Price to Earnings (P/E)-1.4
Beta0.62
Jun 10, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Expense RatioN/A
Share Statistics
EPS (TTM)-0.93
Shares Outstanding51,225,734
10 Day Avg. Volume105,654
30 Day Avg. Volume97,357
Standard Deviation0.19
R-Squared0.04
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)0.86
Price to Sales (P/S)-3.31
Price to Cash Flow (P/CF)-1.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.14
Enterprise Value/Gross Profit0.21
Enterprise Value/Ebitda-0.15
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Ownership Overview

45.59%7.37%22.49%24.54%
45.59% Insiders
22.49% Other Institutional Investors
24.54% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Website Traffic

Sorry, No Data Available
There is no website visitor data available for this stock.
---

ENZ FAQ

What was Enzo Biochem’s price range in the past 12 months?
Enzo Biochem lowest stock price was $1.16 and its highest was $2.74 in the past 12 months.
    What is Enzo Biochem’s market cap?
    Currently, no data Available
    When is Enzo Biochem’s upcoming earnings report date?
    Enzo Biochem’s upcoming earnings report date is Jun 10, 2024 which is in 73 days.
      How were Enzo Biochem’s earnings last quarter?
      Enzo Biochem released its earnings results on Mar 13, 2024. The company reported -$0.061 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.061.
        Is Enzo Biochem overvalued?
        According to Wall Street analysts Enzo Biochem’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Enzo Biochem pay dividends?
          Enzo Biochem does not currently pay dividends.
          What is Enzo Biochem’s EPS estimate?
          Enzo Biochem’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Enzo Biochem have?
          Enzo Biochem has 51,225,735 shares outstanding.
            What happened to Enzo Biochem’s price movement after its last earnings report?
            Enzo Biochem reported an EPS of -$0.061 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.439%.
              Which hedge fund is a major shareholder of Enzo Biochem?
              Among the largest hedge funds holding Enzo Biochem’s share is Evermore Global Advisors, Llc. It holds Enzo Biochem’s shares valued at N/A.
                ---

                Enzo Biochem Stock Smart Score

                Company Description

                Enzo Biochem

                Enzo Biochem, Inc. engages in the development, manufacture and sale of technology solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians globally. It operates through the following segments: Enzo Clinical Laboratory Services, Enzo Life Sciences Products, and Enzo Therapeutics. The Enzo Clinical Laboratory Services segment includes clinical reference laboratory providing a wide range of clinical services to physicians, medical centers, other clinical labs and pharmaceutical companies. The Enzo Life Sciences Products segment manufactures, develops and markets products and tools for clinical research, drug development and bioscience research customers worldwide. The Enzo Therapeutics segment develops multiple novel approaches in the areas of gastrointestinal, infectious, ophthalmic and metabolic diseases, many of which are derived from the pioneering work of Enzo Life Sciences. The company was founded by Elazar Rabbani, Barry W. Weiner and Shahram K. Rabbani in 1976 and is headquartered in New York, NY.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Illumina
                Natera
                QuidelOrtho
                Abbott Labs
                Popular Stocks
                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis